Thursday, July 2, 2020

SEC Charges Alexion Pharmaceuticals With FCPA Violations

The Securities and Exchange Commission today announced that Boston-based pharmaceutical company Alexion Pharmaceuticals Inc. has agreed to pay more than $21 million to resolve charges that it violated the books and records and internal accounting…

Read the Full Press Release
Have a securities law question? Call Sallah Astarita & Cox at 212-509-6544.